Navigation Links
MassMutual Announces Promotions for Two Co-Chief Operating Officers
Date:11/21/2008

SPRINGFIELD, Mass., Nov. 21 /PRNewswire/ -- Massachusetts Mutual Life Insurance Company (MassMutual) today announced the promotions of its two Co-Chief Operating Officers.

-- Roger W. Crandall, Co-Chief Operating Officer, Executive Vice President and Chief Investment Officer, will assume the position of President of MassMutual from Stuart H. Reese, who remains Chairman and Chief Executive Officer. Additionally, Mr. Crandall will become sole Chief Operating Officer and join the company's Board of Directors. His role as Executive Vice President and Chief Investment Officer of MassMutual will be assumed by Thomas M. Finke, who also takes on Mr. Crandall's title as Chairman and CEO of MassMutual subsidiary Babson Capital Management LLC. These appointments are effective Dec. 1, 2008.

-- William F. Glavin Jr., Co-Chief Operating Officer and Executive Vice President, U.S. Insurance Group, MassMutual, has been appointed CEO of OppenheimerFunds, Inc., effective Jan. 1, 2009. In that role, he succeeds John V. Murphy, who will remain as Chairman of OppenheimerFunds until his retirement at the end of 2009. Succeeding Mr. Glavin as Executive Vice President and head of MassMutual's U.S. Insurance Group will be Michael R. Fanning, currently the group's Senior Vice President and Chief Operating Officer. Mr. Fanning's appointment is effective Dec. 1, 2008, and he will report directly to Mr. Crandall.

Both Mr. Crandall and Mr. Glavin -- who have served as Co-Chief Operating Officers since July 2007 -- will continue to report to Mr. Reese.

"At MassMutual, one of our top priorities is the professional development of our leaders, and these promotions reflect the demonstrated capabilities and proven expertise of both Roger and Bill. Over the course of his career, Roger has repeatedly exhibited tremendous investment expertise and leadership skills that have helped MassMutual maintain its fundamental fi
'/>"/>

SOURCE MassMutual
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
2. MassMutual Agent Honored by Insurance Industry for Extraordinary Service to Client
3. Andy Ambrose Joins MassMutuals Institutional Sales Team for Retirement Services
4. MassMutuals Center for Behavioral Research(sm) Releases White Paper Regarding Automatic Features in Retirement Plans
5. MassMutual Offers Free Letter of Intent Template to People with Disabilities and Their Families, Caregivers
6. MassMutuals Center for Behavioral Research(SM) Releases White Paper on Best Practices in Education Campaigns
7. MassMutual Announces Web Site Enhancement That Helps Employees Save for Retirement Sooner
8. Donations, Education, and People-Power Mark MassMutual Breast Cancer Awareness Month Efforts
9. Video: MassMutual Enhances Whole Life Insurance Products - Provides Flexibility, Guarantees
10. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
11. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... Tenn., Nov. 30 During this time o...holidays. For a loved one with Alzheimer,s disease...ends oftentimes struggle with appropriate gift ite...ading providers of senior living residences in the..., offers these suggestions. ,, A listening dev...
(Date:11/30/2009)...se Control and Prevention estimate that well over ...ed with HIV/AIDS. New research from North Carolina...d are minorities and do not have health insurance,...o facilitate education and prevention efforts in m...ch, which analyzed 90,000 HIV patient hospital vis...
(Date:11/30/2009)...thor of "My Two-Year Old Eats Octopus," ...to eat everything. , (PRW... in your house? Do you find yourself acting as a ...ine videos – one focusing on packing lunches...rs for real-life parents’ questions – ...
(Date:11/30/2009)...Colo., Nov. 30 Baxa Corporation is... what "culture of safety" means in today,s pharmac... "Creating a Culture of Safety in Pharmacy ," fea...ssing their experiences with culture of safety, wh...cy and the role of technology in enabling or inhib...
(Date:11/30/2009)..., Nov. 30 Stryker Corpor...agreement to acquire privately held Ascent Health...ocessing and remanufacturing of medical devices in... Stryker will acquire Ascent Healthcare Solutions ...losing is conditioned on the expiration or termina...
Breaking Medicine News(10 mins):Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2Health News:Research highlights need for national HIV strategy 2Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3
...) today announced third quarter and nine months re...ber 31, 2007, Hawkins reported sales,increased 30....ame period a,year ago. Net income for the quarter ...For the nine months ended December 31, 2007, Hawki...
...(Nasdaq: MLAB ) today announced that its Board of...ividend of ten cents per share of common,stock, pa...at the close of,business on February 25, 2008., M...ews release contains forward-looking statements wh...
... (both children and adults) when given gadolinium ... pre-medicated with corticosteroids and antihistam...earchers at the University of Michigan Health Syst...t agents, said Jonathan R. Dillman, MD, lead autho...
... Spending Cuts, ALEXANDRIA, Va., Feb. 8 Presiden...th programs vital to the future of,health and heal...on cut in,Medicaid, the nation,s single largest pa...end on, ranging from poison,control hotlines to fu...
....uk ), the,online ,front door, to the NHS, launche...sense of the stories appearing in the news about m...oices,( http://www.nhs.uk/News/Pages/NewsIndex.asp...g of the science. It,also provides an authoritativ...
...nger is suppressed , , FRIDAY, Feb. 8 (Hea...arriage is communication, and new research now not...tudy of Midwestern couples finds that those who fe...orst thing to do is to keep it in, not talk about ...
Other Medicine News:Health News:Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results 2Health News:Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results 3Health News:Hawkins, Inc. Reports Third Quarter, Nine Months Fiscal 2008 Results 4Health News:Allergic-like reactions occur in premedicated patients 2Health News:Bush Budget Cuts Federal Health Programs Vital to the Health of All Children 2Health News:Bush Budget Cuts Federal Health Programs Vital to the Health of All Children 3Health News:Mutual Resentment in Marriage Can Be Deadly 2Health News:Mutual Resentment in Marriage Can Be Deadly 3
(Date:11/30/2009).... 30 Cytokine PharmaSciences, Inc.... of CPSI-2364, its orally active, small-molecule i...pro-inflammatory cytokines. Results of the safety... volunteers confirm the safety of this compound in... subjects completed the study, including those rec...
(Date:11/30/2009)...PRNewswire/ -- The Simmons law firm,s Trent Miracl...ing thousands of women that were seriously injured...rol pill manufactured and marketed by Bayer Pharma...istrict Litigation has ordered that all federal Ya...idated and centralized for pretrial litigation in ...
(Date:11/30/2009)... 30 According to Millennium Resear...chnology market intelligence, the nearly $1.2 bill...most 5% over 2008 as patients chose to delay or fo... The market will, however, begin recovery in 2010,...ion growth rates of over 15%. MRG,s facial injecta...
Breaking Medicine Technology:Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Cumberland Pharmaceuticals Launches Caldolor 28R 29 in the United States for Treatment of Pain and Fever 56530 1Cumberland Pharmaceuticals Launches Caldolor 28R 29 in the United States for Treatment of Pain and Fever 56530 2Cumberland Pharmaceuticals Launches Caldolor 28R 29 in the United States for Treatment of Pain and Fever 56530 3Cumberland Pharmaceuticals Launches Caldolor 28R 29 in the United States for Treatment of Pain and Fever 56530 4Cumberland Pharmaceuticals Launches Caldolor 28R 29 in the United States for Treatment of Pain and Fever 56530 5Cumberland Pharmaceuticals Launches Caldolor 28R 29 in the United States for Treatment of Pain and Fever 56530 6Cumberland Pharmaceuticals Launches Caldolor 28R 29 in the United States for Treatment of Pain and Fever 56530 7Hard to Treat Diseases Inc 28HTDS 29 and Landstar Inc 28LDSR 29 Cash Reward 56529 1Hard to Treat Diseases Inc 28HTDS 29 and Landstar Inc 28LDSR 29 Cash Reward 56529 2Hard to Treat Diseases Inc 28HTDS 29 and Landstar Inc 28LDSR 29 Cash Reward 56529 3Hard to Treat Diseases Inc 28HTDS 29 and Landstar Inc 28LDSR 29 Cash Reward 56529 4Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 1Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 2Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 3Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 4
...MELBOURNE, Australia, Feb. 11 Phosphagenics,Limit...PGNY) and Nestle,Nutrition (Nestle) today announce... establish the efficacy of Phosphagenics, Phospha ...vancing at three sites in Adelaide,Australia., Ba...ants, the,double-blind phase 2 trial, which is ful...
...BOULDER, Colo., and MONTREAL, Feb. 11 ,Pharmion (N...y announced that,the European Medicines Agency (EM...CD0103, a histone deacetylase (HDAC) inhibitor, as...acute myelogenous leukemia in the,European Union (...duct be,intended for the treatment of life-threate...
Other Medicine Technology:Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 2Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 3Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 4Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 3Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 4
Satin-Slip® 10FR Intubating Stylet
Disposable Aluminum 11 1/2" Stylette
Solid Copper Malleable Stylette
S5000N Ultra-Slip™ Stylet
Medicine Products: